Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: ANDA 3, NDA 1.
| Dosage form | NDCs |
|---|---|
| injection | 4 |
| Route | NDCs |
|---|---|
| intravenous | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| nexus pharamaceuticals inc. | 4 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Emerphed | Ephedrine Sulfate | injection, intravenous | 14789-250NDA |
| Potassium Chloride | Potassium Chloride | injection, intravenous | 14789-107ANDA |
| Potassium Chloride | Potassium Chloride | injection, intravenous | 14789-108ANDA |
| Potassium Chloride | Potassium Chloride | injection, intravenous | 14789-109ANDA |
Compare
Other companies listing potassium chloride
- Cardinal Health 418, Inc.34 sites · 833 NDC
- Lupin Limited14 sites · 506 NDC
- Amneal Pharmaceuticals of New York, LLC14 sites · 227 NDC
- Sun Pharmaceutical Industries Limited13 sites · 918 NDC
- Zydus Lifesciences Limited12 sites · 717 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- Spectrum Pharmaceuticals, Inc.6 sites · 240 NDC
- Pharma Packaging Solutions, LLC dba Tjoapack, LLC5 sites · 667 NDC
Enquiry
Common questions
- Is Nexus Pharamaceuticals Inc. FDA approved?
- Nexus Pharamaceuticals Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Nexus Pharamaceuticals Inc. make?
- 4 products are listed under Nexus Pharamaceuticals Inc. in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.